Last updated: May 6, 2024
Sponsor: I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio
Overall Status: Active - Recruiting
Phase
N/A
Condition
N/ATreatment
There isn't an intervention name because the study is observational and has only one group.
Clinical Study ID
NCT06403254
MRSA
Ages > 40 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria: Patiens male and female, old more than 40 years TKA or THA Surgeryntervento di chirurgiaprotesica ASAC II or even III, without any acute coexisting disease Informed consent -
Exclusion
Exclusion Criteria:Patients with infection before surgery Immunocompromise patient (e.g.Diabeties with glicate HB indicating a metabolic bad compensation) Patient with coagulationdisorders Pregnancy Informed consent denied
Study Design
Total Participants: 700
Treatment Group(s): 1
Primary Treatment: There isn't an intervention name because the study is observational and has only one group.
Phase:
Study Start date:
September 20, 2022
Estimated Completion Date:
November 30, 2024
Study Description
Connect with a study center
Istitutio Ortopedico Galeazzi Sede San Siro
Milan, Lumbardy 20148
ItalyActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.